Description
IGF-LR3 + BPC-157 Blend research blend
IGF-LR3 + BPC-157 Blend combines the long-acting IGF-1 analogue IGF-1 LR3 with BPC-157, supplied as spray, tablets or lyophilised peptide.
Product details
| Compound | IGF-1 LR3 and BPC-157 |
|---|---|
| Class | Two-peptide research blend |
| Form | Nasal Spray (IGF-LR3 + BPC-157); Sublingual Tablets (IGF-LR3 + BPC-157); Peptide (IGF-LR3 + BPC-157); Nasal Spray (IGF-LR3 + BPC-157 Arg); Sublingual Tablets (IGF-LR3 + BPC-157 Arg); Peptide (IGF-LR3 + BPC-157 Arg) |
| Strength | 220mcg per spray/10ml/22mg; 250mcg per tab/30ct/7.5mg; 250mcg per tab/60ct/15mg; 6mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What IGF-LR3 + BPC-157 Blend research has examined
- IGF-1 LR3: growth-factor signalling in culture.
- BPC-157: tissue models.
- Combination research: growth-factor and peptide pairing.
Research interest does not establish a proven effect in humans.
Regulatory status
IGF-LR3 + BPC-157 Blend is a research blend. None of its components is approved for human use in this form, and it is supplied as a research chemical only.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Healing and Repair Research Blend (BPC-157, TB4 Fragment 1-4, GHK-Cu) · BPC-157 + Thymosin Beta-4 + GHK-Cu Blend · Healing and Repair Research Blend: BPC-157 Arg + Thymosin Beta-4 + GHK-Cu · All peptide blends
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.